In this webcast, our tax professionals will discuss key topics related to the New Markets Tax Credit program, including program structure, business eligibility, status of allocation and successful projects.
Do pharmaceutical and life sciences company directors have the right skills and expertise for the New Health Economy?
We bring you PwC’s perspective on deal activity in the pharmaceutical and life sciences industry. Each quarterly publication now features two sections that highlight deal activity and insights from a global view.
This Alert provides an update to those FASB projects that will impact accounting or disclosures related to income taxes that may be of interest to companies in the Pharmaceutical and Life Sciences sector.
US health services deal volume in Q2 2016 increased by approximately 8% from Q1 2016 and 16% on a year-over-year basis. Deal value this quarter increased by nearly 4% compared to Q1 2016, but decreased by 39% when compared to Q2 2015.
In this recorded quarterly webcast focusing on emerging accounting developments affecting not-for-profit organizations, we cover recent FASB standard setting developments, including an update on the not-for-profit financial reporting project, and more.
In this recorded webcast, PwC subject matter specialists discuss how companies can bridge the gap between their current capabilities and a technology-fueled future.
In this edition of Rx Marketplace Quarterly, we discuss the most recent quarter's industry IPOs, venture capital funding, and M&A activity.
PwC's Health & Well-being Touchstone survey is an industry leader in the study of benefit plans offered by US-based employers. In this 2016 report, we dive deep into what US-based employers are doing, and thinking of doing with their benefit programs, strategy and administration.
PwC’s Health Research Institute (HRI) projects a 6.5% growth rate for 2017. Although stagnant, next year’s growth rate still outpaces general economic inflation.